DK1200442T3 - Derivater af 2,3-benzodiazepin - Google Patents

Derivater af 2,3-benzodiazepin

Info

Publication number
DK1200442T3
DK1200442T3 DK00944129T DK00944129T DK1200442T3 DK 1200442 T3 DK1200442 T3 DK 1200442T3 DK 00944129 T DK00944129 T DK 00944129T DK 00944129 T DK00944129 T DK 00944129T DK 1200442 T3 DK1200442 T3 DK 1200442T3
Authority
DK
Denmark
Prior art keywords
sup
bond
positions
hydrogen
lower alkyl
Prior art date
Application number
DK00944129T
Other languages
English (en)
Inventor
Zoltan Greff
Geza Szab
Czy Jozsef Bark
Tkai Zoltan R
Gabor Blask
Gyula Simig
Gabor Gigler
Mark Bernadett Martonn
Vay Gyoergy L
Karoly Tihanyi
Andras Egyed
Annamaria Sim
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Application granted granted Critical
Publication of DK1200442T3 publication Critical patent/DK1200442T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
DK00944129T 1999-07-07 2000-07-04 Derivater af 2,3-benzodiazepin DK1200442T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902291A HU227128B1 (en) 1999-07-07 1999-07-07 New 2,3-benzodiazepine derivatives
PCT/HU2000/000074 WO2001004122A2 (en) 1999-07-07 2000-07-04 New 2,3-benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
DK1200442T3 true DK1200442T3 (da) 2003-10-20

Family

ID=89998666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00944129T DK1200442T3 (da) 1999-07-07 2000-07-04 Derivater af 2,3-benzodiazepin

Country Status (22)

Country Link
US (1) US7053082B1 (da)
EP (1) EP1200442B8 (da)
JP (1) JP2003504372A (da)
KR (1) KR100818001B1 (da)
CN (1) CN1162432C (da)
AT (1) ATE243699T1 (da)
AU (1) AU5836300A (da)
BG (1) BG65405B1 (da)
CA (1) CA2378305A1 (da)
CZ (1) CZ20014698A3 (da)
DE (1) DE60003561T2 (da)
DK (1) DK1200442T3 (da)
HK (1) HK1047581B (da)
HR (1) HRP20020015B1 (da)
HU (1) HU227128B1 (da)
PL (1) PL351839A1 (da)
RO (1) RO121853B1 (da)
RU (1) RU2243228C2 (da)
SK (1) SK286680B6 (da)
UA (1) UA72261C2 (da)
WO (1) WO2001004122A2 (da)
YU (1) YU402A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225100B1 (hu) * 2000-12-21 2006-06-28 Egyt Gyogyszervegyeszeti Gyar 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
EP1979308A1 (en) * 2005-12-30 2008-10-15 EGIS Gyógyszergyár Nyrt Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
FR2972454B1 (fr) * 2011-03-08 2013-03-01 Servier Lab Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179018B (en) * 1978-10-19 1982-08-28 Gyogyszerkutato Intezet Process for producing new 5h-2,3-benzodiazepine derivatives
HU191702B (en) * 1984-06-27 1987-03-30 Gyogyszerkutato Intezet New process for preparing 1-aryl-5 h-2,3-benzodiazepines
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU195788B (en) * 1986-05-21 1988-07-28 Gyogyszerkutato Intezet Process for producing 1-/hydroxy-stiryl/-5h-2,3-benzobiazepines and pharmaceutical compositions containing them
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására
DE4428835A1 (de) * 1994-08-01 1996-02-08 Schering Ag Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
CA2198751C (en) * 1994-08-31 2006-07-11 Benjamin Alan Anderson Dihydro-2,3-benzodiazepine derivatives
US5891871A (en) * 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
EP1015457B1 (en) * 1997-08-12 2003-11-26 Egis Gyogyszergyar Rt. 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors

Also Published As

Publication number Publication date
EP1200442B8 (en) 2003-08-20
AU5836300A (en) 2001-01-30
KR100818001B1 (ko) 2008-03-31
CZ20014698A3 (cs) 2002-06-12
ATE243699T1 (de) 2003-07-15
HRP20020015B1 (en) 2005-02-28
HU9902291D0 (en) 1999-09-28
RU2243228C2 (ru) 2004-12-27
CN1162432C (zh) 2004-08-18
DE60003561T2 (de) 2004-04-29
SK172002A3 (en) 2002-06-04
KR20020022765A (ko) 2002-03-27
WO2001004122A3 (en) 2001-05-10
SK286680B6 (sk) 2009-03-05
HK1047581B (en) 2004-04-30
DE60003561D1 (de) 2003-07-31
WO2001004122A2 (en) 2001-01-18
PL351839A1 (en) 2003-06-16
EP1200442A1 (en) 2002-05-02
EP1200442B1 (en) 2003-06-25
HU227128B1 (en) 2010-07-28
HUP9902291A2 (hu) 2001-12-28
CA2378305A1 (en) 2001-01-18
HK1047581A1 (en) 2003-02-28
JP2003504372A (ja) 2003-02-04
US7053082B1 (en) 2006-05-30
UA72261C2 (uk) 2005-02-15
RO121853B1 (ro) 2008-06-30
BG65405B1 (bg) 2008-06-30
YU402A (sh) 2004-11-25
HRP20020015A2 (en) 2004-08-31
CN1370174A (zh) 2002-09-18
BG106281A (en) 2003-01-31

Similar Documents

Publication Publication Date Title
HUP0303652A2 (hu) Ciklikus származékok, mint kemokin receptor aktivitás modulátorai és ezeket tartalmazó gyógyszerkészítmények
TR200200099T2 (tr) Th2 farklılaşma inhibitörleri
HUP9900617A2 (hu) ACAT gátló és lipoperoxidációt gátló új indol-, indolin- vagy tetrahidrokinolinszármazékok, alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
NZ505586A (en) Indole and cyclopenta(b)pyrrole derivatives and pharmaceuticals thereof; useful as antagonists of the CCR2 (MCP-1) receptor
TW200510440A (en) Novel compounds
NZ514662A (en) Amine derivatives
WO1998009953A3 (de) Azinyloxy- und phenoxy-diaryl-carbonsäure derivate, deren herstellung und deren verwendung als gemischte eta/etb endothelin-rezeptorantagonist
BG104069A (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor
CA2376949A1 (en) Heterocyclic aminopyrrolidine derivatives as melatonergic agents
NO306510B1 (no) Androsteroner, anvendelse derav og farmasöytisk formulering
AU2003207432A1 (en) Urea linker derivatives for use as ppar modulators
DK1034174T3 (da) Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer
TW200510320A (en) Aminoquinoline derivatives and their use as adenosine A3 ligands
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
DE60003561D1 (de) 2,3-benzodiazepinderivate
MY131762A (en) Pharmaceutical compounds
NZ501785A (en) 4-(3,4-dihydro-2-naphthylmethyl)- or 4-(2H-3-chromenylmethyl)-4,5-dihydro-1H-imidazole derivatives
ATE219486T1 (de) Trizyklische indol-2-carbonsäure derivate als selektive nmda rezeptor antagonisten
NO995935D0 (no) 17<beta>-allyloksy(tio)alkyl-androstan-derivater for modulering av meiose
DE60144246D1 (de) Imidazolderivate, verfahren zu deren herstellung und deren verwendung
EP1145713A4 (en) Telomerase inhibitors
AR016184A1 (es) INDOLES 5-HETEROARIL SUSTITUIDOS, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE, LA UTILIZACIoN DE LOS MISMOS PARA LA MANUFACTURA DE UN MEDICAMENTO Y PARA LA PREPARACIoN DE UN COMPUESTO RADIO-MARCADO.
AR023528A1 (es) Derivados de ciclobuten-3,4-diona, su preparacion y su aplicacion en terapeutica